DCM
RMD icon

Davis Capital Management’s ResMed RMD Stock Holding History

Davis Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17K Buy
+6
New +$1.24K ﹤0.01% 465
2026
Q1 		– Sell
-2
Closed -$482 – 634
2025
Q4 		$482 Buy
2
+1
+100% +$256 ﹤0.01% 414
2025
Q3 		$274 Buy
+1
New +$273 ﹤0.01% 508

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Davis Capital Management's RMD Position: Q2 2026 in Review

Davis Capital Management opened a new position in ResMed (RMD) in Q2 2026: 6 shares worth $1.17K. The stake represents ﹤0.01% of the portfolio and ranks #465 among its holdings. This is a return to the name: Davis Capital Management previously reported a position in RMD as recently as Q4 2025.

Davis Capital Management first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Davis Capital Management held 6 shares of ResMed worth $1.17K as of Q2 2026.
  • ResMed was a new Davis Capital Management position in Q2 2026.
  • ResMed made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #465 holding.
  • Davis Capital Management first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.